AngioDynamics ANGO Income Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $78.42M-1.3% | $79.43M+4.9% | $75.71M-5.5% | $80.16M+11.3% | $72M-1.2% | ||
| $36.94M+6.6% | $34.65M+2.4% | $33.85M-10.8% | $37.94M+14.5% | $33.15M+0.6% | ||
| $41.48M-7.4% | $44.78M+7.0% | $41.86M-0.9% | $42.22M+8.6% | $38.86M-2.6% | ||
| 52.9%-3.5pp | 56.4%+1.1pp | 55.3%+2.6pp | 52.7%-1.3pp | 54%-0.8pp | ||
| $7.08M-8.8% | $7.77M+21.1% | $6.42M-2.6% | $6.59M-4.7% | $6.91M+7.4% | ||
| $27.44M+2.7% | $26.71M-5.0% | $28.13M+6.4% | $26.44M+3.7% | $25.5M-0.3% | ||
| $10.72M+5.6% | $10.15M-19.1% | $12.56M+22.7% | $10.24M-2.4% | $10.49M+1.0% | ||
| $2.67M+0.9% | $2.64M-0.4% | $2.65M+2.5% | $2.59M-0.4% | $2.6M+1.4% | ||
| $54.43M+6.9% | $50.91M-3.1% | $52.51M+9.4% | $48.01M-1.7% | $48.83M-4.3% | ||
| $54.43M+6.9% | $50.91M-3.1% | $52.51M+9.4% | $48.01M-1.7% | $48.83M-4.3% | ||
| -$12.95M-111% | -$6.13M+42.5% | -$10.66M-84.1% | -$5.79M+42.0% | -$9.97M+10.1% | ||
| -16.5%-8.8pp | -7.7%+6.4pp | -14.1%-6.9pp | -7.2%+6.6pp | -13.9%+1.4pp | ||
| -$88K+13.7% | -$102K-2,450% | -$4K-233% | $3K-97.8% | $135K-42.3% | ||
| $4.88M+2,221% | -$230K-26.4% | -$182K— | —— | $5.57M+2,162% | ||
| -$8.07M-27.0% | -$6.36M+41.4% | -$10.84M-77.4% | -$6.11M-38.6% | -$4.41M+59.4% | ||
| $12K+340% | -$5K-108% | $65K+208% | -$60K-2,900% | -$2K+98.2% | ||
| -$8.08M-27.3% | -$6.35M+41.8% | -$10.9M-80.2% | -$6.05M-37.3% | -$4.41M+59.0% | ||
| -10.3%-2.3pp | -8%+6.4pp | -14.4%-6.9pp | -7.5%-1.4pp | -6.1%+8.6pp | ||
| -$0.19-26.7% | -$0.15+42.3% | -$0.26-73.3% | -$0.15-36.4% | -$0.11+57.7% | ||
| -$0.19-26.7% | -$0.15+42.3% | -$0.26-73.3% | -$0.15-36.4% | -$0.11+57.7% | ||
| 41.6M+0.1% | 41.5M+0.9% | 41.2M+0.8% | 40.9M0.0% | 40.9M-0.2% | ||
| 41.6M+0.1% | 41.5M+0.9% | 41.2M+0.8% | 40.9M0.0% | 40.9M-0.2% | ||
| $6.52M+79.4% | $3.64M+31.8% | $2.76M+28.0% | $2.16M-34.4% | $3.29M-44.0% | ||
| $0— | $0— | $0— | —— | $40K-74.4% | ||
| $38K-87.6% | $307K+1,237% | -$27K— | —— | $38K-2.6% | ||
| -$88K+13.7% | -$102K-2,450% | -$4K-233% | $3K-97.8% | $135K-42.3% | ||
| $2.67M+0.9% | $2.64M-0.4% | $2.65M+2.5% | $2.59M-0.4% | $2.6M+1.4% | ||
| —— | -$48K-200% | -$16K— | —— | -$207K+16.9% | ||
| -$6.01M— | —— | -$10.7M— | —— | -$10.96M— | ||
| $1.42M-9.6% | $1.57M+1,228% | -$139K+68.9% | -$447K-194% | $474K— | ||
| -$7.06M-315% | $3.28M+1,609% | $192K— | —— | —— | ||
| $4.08M— | —— | $5.53M+144% | -$12.55M-234% | $9.39M+1,329% | ||
| -$315K-32.4% | -$238K+9.8% | -$264K-85.9% | -$142K-373% | -$30K— | ||
| $4.97M+3,980% | -$128K+28.1% | -$178K— | $0-100% | $5.43M+45,150% | ||
| —— | —— | —— | $1.48M0.0% | $1.48M0.0% | ||
| $0— | $0— | $0— | —— | —— | ||
| $1.02M+141% | $422K-42.3% | $731K-5.9% | $777K-56.8% | $1.8M+126% | ||
| $317K+235% | -$235K-318% | $108K-36.1% | $169K+19.0% | $142K+20.3% | ||
| $78.42M-1.3% | $79.43M+4.9% | $75.71M-5.5% | $80.16M+11.3% | $72M-1.2% | ||
| $2.68M-7.2% | $2.89M-35.3% | $4.47M+172% | $1.64M-31.6% | $2.4M-5.1% | ||
| -$12.95M-111% | -$6.13M+42.5% | -$10.66M-84.1% | -$5.79M+42.0% | -$9.97M+10.1% | ||
| -$7.36M-1,847% | -$378K+91.8% | -$4.64M-10,402% | $45K+101% | -$3.66M+13.6% | ||
| -$7.36M-1,847% | -$378K+91.8% | -$4.64M-10,402% | $45K+101% | -$3.66M+13.6% | ||
| -9.4%-8.9pp | -0.5%+5.6pp | -6.1%-6.2pp | 0.1%+5.1pp | -5.1%+0.7pp | ||
| -$12.95M-111% | -$6.13M+42.5% | -$10.66M-84.1% | -$5.79M+42.0% | -$9.97M+10.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is AngioDynamics's revenue?
- AngioDynamics (ANGO) generated $313.7M in revenue over the trailing twelve months, up 10.7% year over year.
- Is AngioDynamics profitable?
- AngioDynamics is not currently profitable: it reported a net loss of $31.4M over the trailing twelve months, a -10.0% net margin.
- What are AngioDynamics's profit margins?
- Gross margin is 54.3% and operating margin is -11.3%, with a -10.0% net margin.
- What is AngioDynamics's earnings per share?
- AngioDynamics's diluted EPS over the trailing twelve months is $-0.75.
- Where does AngioDynamics's income statement data come from?
- Every line is extracted from AngioDynamics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
